On this episode of Women @ RopesTalk hosted by IP transactions partner Megan Baca, IP transactions counsel Georgina Suzuki returns for another engaging conversation, this time with Svetlana Lucas, PhD, the chief business officer at Scribe Therapeutics, a biotech company that develops and engineers advanced CRISPR-based therapies for a wide range of diseases. Svetlana shares her journey in the biotech industry, the challenges and opportunities she has encountered, and her insights on the future of CRISPR technology. She also discusses the importance of relationships, diversity, and mentorship in the industry, and embracing the concept of “being comfortable with being uncomfortable.”
